Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PNMT | P11086 | 6/20 | 0.52 |
| ▸ | DRD2 | P14416 | 4/20 | 0.52 |
| ▸ | DRD3 | P35462 | 4/20 | 0.52 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.46 |
| ▸ | KDM1A | O60341 | 2/20 | 0.41 |
| ▸ | MAOA | P21397 | 1/20 | 0.41 |
| ▸ | MAOB | P27338 | 1/20 | 0.41 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.40 |
| ▸ | CYP11B1 | P15538 | 3/20 | 0.40 |
| ▸ | CYP11B2 | P19099 | 3/20 | 0.40 |
| ▸ | HTR2A | P28223 | 1/20 | 0.40 |
| ▸ | HTR2C | P28335 | 1/20 | 0.40 |
| ▸ | HTR2B | P41595 | 1/20 | 0.40 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30950987 | 1.00 | PNMT (0.52) | PNMTDRD2DRD3TRPA1KDM1A | |
| SCHEMBL11678763 | 0.94 | PNMT (0.47) | PNMTDRD2DRD3TRPA1KDM1A | |
| SCHEMBL2355804 | 0.90 | SMN1; SMN2 (0.53) | PNMTDRD2DRD3TRPA1MAOA | |
| SCHEMBL31441011 | 0.90 | SMN1; SMN2 (0.53) | PNMTDRD2DRD3TRPA1MAOA | |
| SCHEMBL10960822 | 0.88 | MAOA (0.55) | PNMTDRD2DRD3TRPA1MAOA | |
| SCHEMBL16335512 | 0.88 | PNMT (0.43) | PNMTDRD2DRD3TRPA1MAOA | |
| SCHEMBL6739755 | 0.88 | — | — | |
| SCHEMBL28439114 | 0.87 | MAOA (0.50) | PNMTDRD2DRD3TRPA1MAOA | |
| Bromide SCHEMBL17202846 | 0.86 | PNMT (0.52) | PNMTDRD2DRD3TRPA1KDM1A | |
| SCHEMBL11676256 | 0.86 | PNMT (0.47) | PNMTDRD2DRD3TRPA1KDM1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3943492-B1 | TADF MATERIALS COMPRISING 4-(3-(2-(10H-PHENOXAZIN-10-YL)PYRIDIN-5-YL)-9H-CARBAZOL-9-YL)BENZONITRILE DERIVATIVES AND RELATED COMPOUNDS FOR USE IN OLEDS | NOCTILUCA S A (PL) | 2024-05-08 | — | — | EP | claimed |
| EP-3943492-A1 | TADF MATERIALS COMPRISING 4-(3-(2-(10H-PHENOXAZIN-10-YL)PYRIDIN-5-YL)-9H-CARBAZOL-9-YL)BENZONITRILE DERIVATIVES AND RELATED COMPOUNDS FOR USE IN OLEDS | Noctiluca S.A. (PL) | 2022-01-26 | — | — | EP | claimed |
| US-12565613-B2 | Quantum dots with donor-acceptor ligands | SHOEI CHEMICAL INC. (JP) | 2026-03-03 | — | — | US | disclosed |
| EP-4372057-A2 | TADF MATERIALS COMPRISING 4-(3-(2-(10H-PHENOXAZIN-10-YL)PYRIDIN-5-YL)-9H-CARBAZOL-9-YL)BENZONITRILE DERIVATIVES AND RELATED COMPOUNDS FOR USE IN OLEDS | Noctiluca S.A. (PL) | 2024-05-22 | — | — | EP | disclosed |
| EP-3943492-B1 | TADF MATERIALS COMPRISING 4-(3-(2-(10H-PHENOXAZIN-10-YL)PYRIDIN-5-YL)-9H-CARBAZOL-9-YL)BENZONITRILE DERIVATIVES AND RELATED COMPOUNDS FOR USE IN OLEDS | NOCTILUCA S A (PL) | 2024-05-08 | — | — | EP | disclosed |
| CN-113603628-B | Non-conjugated space charge transfer thermal activation delay fluorescent material and electroluminescent application thereof | 华中师范大学 | 2023-11-21 | — | — | CN | disclosed |
| WO-2023178136-A2 | STRETCHABLE LIGHT-EMITTING POLYMERS | THE UNIVERSITY OF CHICAGO (US) | 2023-09-21 | — | — | WO | disclosed |
| US-11647671-B2 | Compound and organic electro-optical device containing the same | WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) | 2023-05-09 | — | — | US | disclosed |
| US-20230036119-A1 | QUANTUM DOTS WITH DONOR-ACCEPTOR LIGANDS | NANOSYS, INC. | 2023-02-02 | — | — | US | disclosed |
| US-20230036119-A1 | QUANTUM DOTS WITH DONOR-ACCEPTOR LIGANDS | NANOSYS, INC. | 2023-02-02 | — | — | US | disclosed |
| CN-111995513-B | Preparation method of 9-hydroxymethyl-fluorenic acid | 天津键凯科技有限公司 | 2022-11-01 | — | — | CN | disclosed |
| EP-0973750-B1 | SUBSTITUTED BENZIMIDAZOLES AND THEIR USE FOR TREATING RETROVIRAL INFECTION | UNIV NORTH CAROLINA (US) | 2004-04-21 | — | — | EP | disclosed |
| US-6326395-B1 | AMIDINE OR AMIDE SUBSTITUTED FURAN DERIVATIVES | DUKE UNIVERSITY | 2001-12-04 | — | — | US | disclosed |
| EP-1143959-A2 | ANTIFUNGAL ACTIVITY OF DICATIONIC MOLECULES | UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2001-10-17 | — | — | EP | disclosed |
| WO-2000015212-A2 | ANTIFUNGAL ACTIVITY OF DICATIONIC MOLECULES | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2000-03-23 | — | — | WO | disclosed |
| EP-0973750-A1 | SUBSTITUTED BENZIMIDAZOLES AND THEIR USE FOR TREATING RETROVIRAL INFECTION | The University of North Carolina at Chapel Hill (US) | 2000-01-26 | — | — | EP | disclosed |
| US-5935982-A | ADMINISTERING ARYLENEBIS((AMIDINO)-2-BENZIMIDAZOLE) DERIVATIVES TO TREAT HUMAN T-CELL LEUKEMIA/LYMPHOMA VIRUS | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 1999-08-10 | — | — | US | disclosed |
| WO-1998038170-A1 | SUBSTITUTED BENZIMIDAZOLES AND THEIR USE FOR TREATING RETROVIRAL INFECTION | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 1998-09-03 | — | — | WO | disclosed |
| US-5066769-A | Terephthalic acid, 2,7-fluorenedicarboxylic acid, and diaminodimercaptobenzene dihydrochloride monomers; compressive strength | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE (US) | 1991-11-19 | — | — | US | disclosed |
| US-4064347-A | Bis-basic ketones of fluorene and fluorenone | RICHARDSON-MERRELL INC. (US) | 1977-12-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12565613-B2 | Quantum dots with donor-acceptor ligands | HCCS, FDPS, FTH1 | PNMT 4230/4885DRD2 680/4885DRD3 366/4885 |
| US-11647671-B2 | Compound and organic electro-optical device containing the same | EPCAM, LPO, CYBA | PNMT 1099/4885DRD2 2618/4885DRD3 2958/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.